Joshua Zeidner: The prognostic influence of monocytic phenotypes in patients treated with Azacitidine and Venetoclax

Joshua Zeidner: The prognostic influence of monocytic phenotypes in patients treated with Azacitidine and Venetoclax

Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X:

“Fantastic presentation by Curtis Lachowiez showing the significant prognostic influence of monocytic phenotypes in pts treated with Aza/Ven. In NPM1 wt, monocytic phenotypes led to significantly worse outcomes. Differentiation state should be incorporated into our risk scores.”

Curtis Lachowiez, Assistant Professor of Medicine at Oregon Health and Science University, shared this post, adding:

“Thank you Joshua Zeidner and Daniel Pollyea for the collaboration on this project. Excited for more to come!”